84 results on '"Acton, Gary"'
Search Results
2. The LILY Database: Linking Lithology to IODP Physical, Chemical, and Magnetic Properties Data
3. Supplementary Table 1 from A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study
4. Supplementary Figure 1 from A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study
5. On the relationship between paleomagnetic secular variation and excursions – Records from MIS 9 and 10 - ODP Leg 172
6. Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs
7. Relationships between lithology and chemical properties: mining the IODP databas
8. Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton’s tyrosine kinase inhibitor vecabrutinib in B-cell malignancies
9. On the relationship between paleomagnetic secular variation and excursions – Records from MIS 6 and 7 - ODP Leg 172
10. On the relationship between palaeomagnetic secular variation and excursions—records from MIS 8–ODP Leg 172
11. Magnetic Mineralogy of a Complete Oceanic Crustal Section (IODP Hole 1256D)
12. Rock Magnetic Characterization Through an Intact Sequence of Oceanic Crust, IODP Hole 1256D
13. Absolute Paleointensities from an Intact Section of Oceanic Crust Cored at ODP/IODP Site 1256 in the Equatorial Pacific
14. The late Eocene greenhouse-icehouse transition: Observations from the Massignano global stratotype section and point (GSSP)
15. Climate‐Induced Variability in Mediterranean Outflow to the North Atlantic Ocean During the Late Pleistocene
16. Global and regional geomagnetic variabilities recorded in late Quaternary sediments from the west Iberian Margin
17. Environmental and rock magnetic investigations into provenance and processes of west Iberian margin sediments
18. Mining the IODP Database for Relationships Between Lithology and Physical, Chemical, and Magnetic Properties
19. Ongoing Results of a Phase 1B/2 Dose-Escalation and Cohort-Expansion Study of the Selective, Noncovalent, Reversible Bruton'S Tyrosine Kinase Inhibitor, Vecabrutinib, in B-Cell Malignancies
20. Miocene Glacial Dynamics Recorded by Variations in Magnetic Properties in the ANDRILL‐2A Drill Core
21. Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3
22. Clinical proof of concept for a safe and effective NF ‐κB‐targeting strategy in multiple myeloma
23. Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
24. A randomised, double-blind, placebo-controlled phase IIa trial of AMG319 given orally as neoadjuvant therapy in patients with human papillomavirus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC).
25. Depositional setting, provenance, and tectonic-volcanic setting of Eocene–Recent deep-sea sediments of the oceanic Izu–Bonin forearc, northwest Pacific (IODP Expedition 352)
26. Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience
27. Erratum: Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
28. Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
29. Cancer-Selective Targeting of the NF-κB Survival Pathway in Multiple Myeloma with the GADD45β/MKK7 Inhibitor, DTP3
30. A reference time scale for Site U1385 (Shackleton Site) on the SW Iberian Margin
31. Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents
32. Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
33. Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience.
34. Early to middle Miocene vegetation history of Antarctica supports eccentricity-paced warming intervals during the Antarctic icehouse phase
35. A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study
36. Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR)
37. Paleomagnetism and plate tectonics
38. Insights into magmatic processes and hydrothermal alteration of in situ superfast spreading ocean crust at ODP/IODP site 1256 from a cluster analysis of rock magnetic properties
39. Onset of Mediterranean outflow into the North Atlantic
40. A middle Miocene relative paleointensity record from the Equatorial Pacific
41. Middle Eocene to early Oligocene calcareous nannofossil biostratigraphy at IODP Site U1333 (equatorial Pacific)
42. Rock-magnetic artifacts on long-term relative paleointensity variations in sediments
43. A Cenozoic record of the equatorial Pacific carbonate compensation depth
44. VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia.
45. A detailed paleomagnetic record between 2.1 and 2.75 Ma at IODP Site U1314 in the North Atlantic: Geomagnetic excursions and the Gauss-Matuyama transition
46. Strengthening of North American dust sources during the late Pliocene (2.7Ma)
47. Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor–Positive Locally Advanced or Metastatic Breast Cancer
48. Essentials of Paleomagnetism
49. A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
50. Millennial-scale iceberg surges after intensification of Northern Hemisphere glaciation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.